Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase II study is to determine the recommended dose, as well as the
safety and efficacy of the combination of oxaliplatin, leucovorin and 5-Fu introduced by
hepatic arterial infusion chemotherapy (HAIC) in patients with advanced hepatocellular
carcinoma (HCC).